AbbVie Story

AbbVie -- USA Stock  

USD 92.60  0.41  0.44%

Macroaxis does not monitor all media channels or aggregates social signals for AbbVie. But even though we do not provide professional-grade financial sentiment analysis on AbbVie, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for AbbVie. Check also AbbVie Hype Analysis, AbbVie Correlation and AbbVie Performance.
Acquisition by Robert Alpern of tradable shares of AbbVie subject to Rule 16b-3
Filed transaction by Abbvie Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

AbbVie Inc insider trading alert for grant of stock equivalent units by Robert Alpern, the corporate stakeholder, on January 3, 2018. This event was filed by Abbvie Inc with SEC on 2018-01-03. Statement of changes in beneficial ownership - SEC Form 4

Cash Floor Correlation

Click cells to compare fundamentals   View All Correlations

Story Momentum

This media report from MacroaxisInsider distributed on January 3, 2018 was a factor to the next trading day price decrease.The overall trading delta against the next closing price was 0.57% . The overall trading delta when the story was published against the current closing price is 6.54% .

Similar stores for AbbVie

Why is the 200 Simple Moving Average so common for traders and analysts AbbVie Inc., NYSE ABBV
DailyNyseNews Full coverage
over a month ago at 
AbbVie exotic insider transaction detected
Macroaxis News
Filed transaction by Abbvie Inc officer. Unconventional Insider trading
over two months ago at 
Sale by Richard Gonzalez of 100 shares of AbbVie
Macroaxis News
Filed transaction by Abbvie Inc director. General open market or private sale of non-derivative or derivative security

Did you try this?

Run Price Exposure Probability Now

Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
View All  NextLaunch Price Exposure Probability

Z Score

Z Score Comparative Analysis
  Z Score 
      AbbVie Comparables 
AbbVie is currently under evaluation in z score category among related companies. Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in late 1960s at New York University..


AbbVie Related Equities
MRK  0.32 %   
AGN  0.05 %   
BIO  0.6 %   
BMY  0.85 %   
LLY  0.87 %   
VRTX  0.88 %   
ABT  1.15 %   
MNK  1.99 %   
ENDP  2.13 %   
Check also AbbVie Hype Analysis, AbbVie Correlation and AbbVie Performance. Please also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. drill down to check world indexes.